molgramostim

{{Short description|Chemical compound}}

{{Missing information|indication, producer, ...|date=November 2017}}

{{Drugbox

| verifiedrevid = 444433060

| IUPAC_name =

| image =

| tradename =

| Drugs.com = {{drugs.com|international|molgramostim}}

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number_Ref = {{cascite|correct|CAS}}

| CAS_number = 99283-10-0

| ATC_prefix = L03

| ATC_suffix = AA03

| PubChem =

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = B321AL142J

| ChemSpiderID = none

| chemical_formula =

| molecular_weight =

}}

Molgramostim is a recombinant granulocyte macrophage colony-stimulating factor which functions as an immunostimulator.{{cite journal |vauthors=Quittet P, Ceballos P, Lopez E, etal |title=Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients |journal=Bone Marrow Transplant. |volume=38 |issue=4 |pages=275–84 |year=2006 |pmid=16883311 |doi=10.1038/sj.bmt.1705441 |pmc=2100150|url=http://www.hal.inserm.fr/inserm-00136076/document }}{{cite journal |vauthors=Orozco H, Arch J, Medina-Franco H, etal |title=Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial |journal=Archives of Surgery |volume=141 |issue=2 |pages=150–3; discussion 154 |year=2006 |pmid=16490891 |doi=10.1001/archsurg.141.2.150|doi-access=free }}